Auryx Raises $2M to Transform Earbuds Into Health Monitors

Why It Matters

Acoustic health monitoring could disrupt the wearables market by offering more reliable, sensor‑free vital‑sign tracking, unlocking new revenue streams for device makers and expanding access to continuous health data.

Key Takeaways

• auryx secured $2M pre‑seed led by Celero Ventures
• Uses earbud microphones to capture heart, lung, blood flow data
• Acoustic sensing avoids motion artefacts common in wrist wearables
• Targets hundreds of millions of existing earbud users for health monitoring
• Will expand to other microphone‑equipped devices beyond earbuds

Pulse Analysis

auryx is translating years of Cambridge research into a commercial platform that reads physiological signals from the acoustic output of everyday devices. By leveraging the tiny microphones already built into earbuds, the startup can extract heart‑rate, respiratory rate, cardiac output and even blood‑pressure estimates from the subtle sounds of blood flow and lung activity. This acoustic approach sidesteps the motion artefacts that plague optical sensors on wrist‑worn wearables, delivering cleaner data without adding any hardware. The result is a truly passive, continuous health monitor that works as users listen to music or take calls.

The timing aligns with a surge in earbud adoption; global shipments now exceed 300 million units annually, creating a massive installed base for auryx’s technology. By embedding health analytics into devices that consumers already own, the company can accelerate market penetration without the friction of a dedicated sensor. Investors such as Celero Ventures see the model as a way to monetize existing hardware through software licences and data services, potentially opening new revenue streams for manufacturers like Apple, Samsung and emerging audio brands. Early commercial partnerships could embed the platform into next‑generation earbuds, smart glasses and hearing aids.

Scaling the solution will require robust machine‑learning models, regulatory clearance and seamless integration with diverse hardware ecosystems. auryx’s $2 million pre‑seed round will fund hardware‑software co‑design, model refinement and team expansion, positioning the startup to meet FDA and CE requirements for medical‑grade monitoring. If successful, acoustic health monitoring could broaden the wearables landscape beyond optical photoplethysmography, prompting a shift toward multi‑modal sensors that capture a richer set of vital signs. The move may also spark competitive R&D as larger players seek to incorporate sound‑based diagnostics into their product roadmaps.